Market Summary

Introduction

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Inhalation Anaesthesia Market Overview 

    3.1    Global Inhalation Anaesthesia Market Historical Value (2017-2023) 
    3.2    Global Inhalation Anaesthesia Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Inhalation Anaesthesia Market Landscape*
    5.1    Global Inhalation Anaesthesia: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Inhalation Anaesthesia: Product Landscape 
        5.2.1    Analysis by Drug Type
        5.2.2    Analysis by Application
6    Global Inhalation Anaesthesia Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis 
        6.3.1    Political 
        6.3.2    Economic 
        6.3.3    Social 
        6.3.4    Technological 
        6.3.5    Legal 
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Inhalation Anaesthesia Market Segmentation (2017-2032)
    7.1    Global Inhalation Anaesthesia Market (2017-2032) by Drug Type
        7.1.1    Market Overview
        7.1.2    Sevoflurane
        7.1.3    Desflurane
        7.1.4    Isoflurane
        7.1.5    Halothane
    7.2    Global Inhalation Anaesthesia Market (2017-2032) by Application
        7.2.1    Market Overview
        7.2.2    Induction
        7.2.3    Maintenance
    7.3    Global Inhalation Anaesthesia Market (2017-2032) by Region
        7.3.1    Market Overview
        7.3.2    North America 
        7.3.3    Europe
        7.3.4    Asia Pacific
        7.3.5    Latin America
        7.3.6    Middle East and Africa
8    North America Inhalation Anaesthesia Market (2017-2032)
    8.1    North America Inhalation Anaesthesia Market (2017-2032) by Drug Type
        8.1.1    Market Overview
        8.1.2    Sevoflurane
        8.1.3    Desflurane
        8.1.4    Isoflurane
        8.1.5    Halothane
    8.2    North America Inhalation Anaesthesia Market (2017-2032) by Application
        8.2.1    Market Overview
        8.2.2    Induction
        8.2.3    Maintenance
    8.3    North America Inhalation Anaesthesia Market (2017-2032) by Country
        8.3.1    United States of America
        8.3.2    Canada
9    Europe Inhalation Anaesthesia Market (2017-2032)
    9.1    Europe Inhalation Anaesthesia Market (2017-2032) by Drug Type
        9.1.1    Market Overview
        9.1.2    Sevoflurane
        9.1.3    Desflurane
        9.1.4    Isoflurane
        9.1.5    Halothane
    9.2    Europe Inhalation Anaesthesia Market (2017-2032) by Application
        9.2.1    Market Overview
        9.2.2    Induction
        9.2.3    Maintenance
    9.3    Europe Inhalation Anaesthesia Market (2017-2032) by Country
        9.3.1    United Kingdom
        9.3.2    Germany
        9.3.3    France
        9.3.4    Italy
        9.3.5    Others
10    Asia Pacific Inhalation Anaesthesia Market (2017-2032)
    10.1    Asia Pacific Inhalation Anaesthesia Market (2017-2032) by Drug Type
        10.1.1    Market Overview
        10.1.2    Sevoflurane
        10.1.3    Desflurane
        10.1.4    Isoflurane
        10.1.5    Halothane
    10.2    Asia Pacific Inhalation Anaesthesia Market (2017-2032) by Application
        10.2.1    Market Overview
        10.2.2    Induction
        10.2.3    Maintenance
    10.3    Asia Pacific Inhalation Anaesthesia Market (2017-2032) by Country
        10.3.1    China
        10.3.2    Japan
        10.3.3    India
        10.3.4    ASEAN
        10.3.5    Australia
        10.3.6    Others
11    Latin America Inhalation Anaesthesia Market (2017-2032)
    11.1     Latin America Inhalation Anaesthesia Market (2017-2032) by Drug Type
        11.1.1    Market Overview
        11.1.2    Sevoflurane
        11.1.3    Desflurane
        11.1.4    Isoflurane
        11.1.5    Halothane
    11.2    Latin America Inhalation Anaesthesia Market (2017-2032) by Application
        11.2.1    Market Overview
        11.2.2    Induction
        11.2.3    Maintenance
    11.3    Latin America Inhalation Anaesthesia Market (2017-2032) by Country
        11.3.1    Brazil
        11.3.2    Argentina
        11.3.3    Mexico
        11.3.4    Others
12    Middle East and Africa Inhalation Anaesthesia Market (2017-2032)
    12.1     Middle East and Africa Inhalation Anaesthesia Market (2017-2032) by Drug Type
        12.1.1    Market Overview
        12.1.2    Sevoflurane
        12.1.3    Desflurane
        12.1.4    Isoflurane
        12.1.5    Halothane
    12.2    Middle East and Africa Inhalation Anaesthesia Market (2017-2032) by Application
        12.2.1    Market Overview
        12.2.2    Induction
        12.2.3    Maintenance
    12.3    Middle East and Africa Inhalation Anaesthesia Market (2017-2032) by Country
        12.3.1    Saudi Arabia
        12.3.2    United Arab Emirates
        12.3.3    Nigeria
        12.3.4    South Africa
        12.3.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Patent  Analysis
    14.1     Analysis by Type of Patent
    14.2     Analysis by Publication Year
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Patent Age
    14.5     Analysis by CPC Analysis
    14.6     Analysis by Patent Valuation 
    14.7     Analysis by Key Players
15    Clinical Trial Analysis
    15.1    Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Grant Analysis
    16.1    Analysis by Year
    16.2    Analysis by Amount Awarded
    16.3    Analysis by Issuing Authority
    16.4    Analysis by Grant Product
    16.5    Analysis by Funding Institute
    16.6    Analysis by Departments
    16.7    Analysis by Recipient Organization
17    Funding and Investment Analysis
    17.1     Analysis by Funding Instances
    17.2     Analysis by Type of Funding
    17.3     Analysis by Funding Amount
    17.4     Analysis by Leading Players
    17.5     Analysis by Leading Investors
    17.6     Analysis by Geography
18    Strategic Initiatives
    18.1     Analysis by Partnership Instances
    18.2     Analysis by Type of Partnership
    18.3     Analysis by Leading Players
    18.4     Analysis by Geography
19    Supplier Landscape
    19.1    Market Share Analysis, By Region (Top 5 Companies)
        19.1.1    Market Share Analysis: Global
        19.1.2    Market Share Analysis: North America
        19.1.3    Market Share Analysis: Europe
        19.1.4    Market Share Analysis: Asia Pacific
        19.1.5    Market Share Analysis: Others
    19.2    Halocarbon Life Sciences, LLC . 
        19.2.1    Financial Analysis
        19.2.2    Product Portfolio
        19.2.3    Demographic Reach and Achievements
        19.2.4    Mergers and Acquisitions
        19.2.5    Certifications 
    19.3    Baxter International Inc 
        19.3.1    Financial Analysis
        19.3.2    Product Portfolio
        19.3.3    Demographic Reach and Achievements
        19.3.4    Mergers and Acquisitions
        19.3.5    Certifications
    19.4    AbbVie Inc . 
        19.4.1    Financial Analysis
        19.4.2    Product Portfolio
        19.4.3    Demographic Reach and Achievements
        19.4.4    Mergers and Acquisitions
        19.4.5    Certifications
    19.5    Sandoz AG 
        19.5.1    Financial Analysis
        19.5.2    Product Portfolio
        19.5.3    Demographic Reach and Achievements
        19.5.4    Mergers and Acquisitions
        19.5.5    Certifications
    19.6    Piramal Enterprises Ltd .
        19.6.1    Financial Analysis
        19.6.2    Product Portfolio
        19.6.3    Demographic Reach and Achievements
        19.6.4    Mergers and Acquisitions
        19.6.5    Certifications
    19.7    Dechra Pharmaceuticals PLC 
        19.7.1    Financial Analysis
        19.7.2    Product Portfolio
        19.7.3    Demographic Reach and Achievements
        19.7.4    Mergers and Acquisitions
        19.7.5    Certifications
    19.8    Fresenius Kabi AG 
        19.8.1    Financial Analysis
        19.8.2    Product Portfolio
        19.8.3    Demographic Reach and Achievements
        19.8.4    Mergers and Acquisitions
        19.8.5    Certifications
    19.9    Hikma Pharmaceuticals PLC 
        19.9.1    Financial Analysis
        19.9.2    Product Portfolio
        19.9.3    Demographic Reach and Achievements
        19.9.4    Mergers and Acquisitions
        19.9.5    Certifications 
    19.10    Jiangsu Hengrui Medicine Co. Ltd 
        19.10.1    Financial Analysis
        19.10.2    Product Portfolio
        19.10.3    Demographic Reach and Achievements
        19.10.4    Mergers and Acquisitions
        19.10.5    Certifications 
    19.11    Lunan Pharmaceutical Group Co. Ltd 
        19.11.1    Financial Analysis
        19.11.2    Product Portfolio
        19.11.3    Demographic Reach and Achievements
        19.11.4    Mergers and Acquisitions
        19.11.5    Certifications
    19.12    Merck KGaA 
        19.12.1    Financial Analysis
        19.12.2    Product Portfolio
        19.12.3    Demographic
        19.12.4    Mergers and Acquisitions
        19.12.5    Certifications
    19.13    Troikaa Pharmaceuticals Ltd  
        19.13.1    Financial Analysis
        19.13.2    Product Portfolio
        19.13.3    Demographic Reach and Achievements
        19.13.4    Mergers and Acquisitions
        19.13.5    Certifications 
20    Inhalation Anaesthesia Market – Distribution Model (Additional Insight)
    20.1     Overview 
    20.2     Potential Distributors 
    20.3     Key Parameters for Distribution Partner Assessment 
21    Key Opinion Leaders (KOL) Insights (Additional Insight)

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

 

**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom request.

*Additional insights provided are customizable as per client requirements.

*The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

*The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124